{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:25:59Z","timestamp":1789122359516,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-42","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T17:38:57Z","timestamp":1337103537000},"source":"Crossref","is-referenced-by-count":27,"title":["Antipsychotic polypharmacy in a regional health service: a population-based study"],"prefix":"10.1186","volume":"12","author":[{"given":"Miguel","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Zara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Serrano-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"issue":"2","key":"1076_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/01.pra.0000265773.03756.3e","volume":"13","author":"JL Megna","year":"2007","unstructured":"Megna JL, Kunwar AR, Mahlotra K, Sauro MD, Devitt PJ, Rashid A: A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness. J Psychiatr Pract. 2007, 13 (2): 129-137. 10.1097\/01.pra.0000265773.03756.3e.","journal-title":"J Psychiatr Pract"},{"issue":"3","key":"1076_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1176\/appi.ajp.2007.07111738","volume":"165","author":"M Hazra","year":"2008","unstructured":"Hazra M, Mamo DC, Remington G: Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects. Am J Psychiatry. 2008, 165 (3): 396-397. 10.1176\/appi.ajp.2007.07111738. author reply 397\u2013398","journal-title":"Am J Psychiatry"},{"issue":"7","key":"1076_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1176\/ps.2007.58.7.1007","volume":"58","author":"TP Gilmer","year":"2007","unstructured":"Gilmer TP, Dolder CR, Folsom DP, Mastin W, Jeste DV: Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999\u20132004. Psychiatr Serv. 2007, 58 (7): 1007-1010. 10.1176\/appi.ps.58.7.1007.","journal-title":"Psychiatr Serv"},{"issue":"7","key":"1076_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1176\/ps.2007.58.7.983","volume":"58","author":"J Kreyenbuhl","year":"2007","unstructured":"Kreyenbuhl J, Marcus SC, West JC, Wilk J, Olfson M: Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatr Serv. 2007, 58 (7): 983-990. 10.1176\/appi.ps.58.7.983.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"1076_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2007-970062","volume":"40","author":"YT Xiang","year":"2007","unstructured":"Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS: Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Pharmacopsychiatry. 2007, 40 (2): 47-52. 10.1055\/s-2007-970062.","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"1076_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1176\/ps.2007.58.4.489","volume":"58","author":"JA Kreyenbuhl","year":"2007","unstructured":"Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC: Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv. 2007, 58 (4): 489-495. 10.1176\/appi.ps.58.4.489.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"1076_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.clinthera.2007.01.002","volume":"29","author":"EH Morrato","year":"2007","unstructured":"Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ: Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998\u20132003. Clin Ther. 2007, 29 (1): 183-195. 10.1016\/j.clinthera.2007.01.002.","journal-title":"Clin Ther"},{"issue":"3","key":"1076_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11096-006-9063-1","volume":"29","author":"WJ Broekema","year":"2007","unstructured":"Broekema WJ, de Groot IW, van Harten PN: Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharm World Sci. 2007, 29 (3): 126-130. 10.1007\/s11096-006-9063-1.","journal-title":"Pharm World Sci"},{"issue":"12","key":"1076_CR9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005, 353 (12): 1209-1223. 10.1056\/NEJMoa051688.","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"1076_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","volume":"89","author":"CU Correll","year":"2007","unstructured":"Correll CU, Frederickson AM, Kane JM, Manu P: Does antipsychotic polypharmacy increase the risk for metabolic syndrome?. Schizophr Res. 2007, 89 (1\u20133): 91-100.","journal-title":"Schizophr Res"},{"issue":"10","key":"1076_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4088\/JCP.v65n1013","volume":"65","author":"R Ganguly","year":"2004","unstructured":"Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC: Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998\u20132000. J Clin Psychiatry. 2004, 65 (10): 1377-1388. 10.4088\/JCP.v65n1013.","journal-title":"J Clin Psychiatry"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-244X-5-26","volume":"5","author":"D Faries","year":"2005","unstructured":"Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J: Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry. 2005, 5: 26-10.1186\/1471-244X-5-26.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"1076_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2006.02.023","volume":"84","author":"J Kreyenbuhl","year":"2006","unstructured":"Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC: Long-term combination antipsychotic treatment in VA patients with schizophrenia. Schizophr Res. 2006, 84 (1): 90-99. 10.1016\/j.schres.2006.02.023.","journal-title":"Schizophr Res"},{"issue":"1","key":"1076_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1176\/appi.ps.54.1.55","volume":"54","author":"A Tapp","year":"2003","unstructured":"Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N: Combination antipsychotic therapy in clinical practice. Psychiatr Serv. 2003, 54 (1): 55-59. 10.1176\/appi.ps.54.1.55.","journal-title":"Psychiatr Serv"},{"issue":"5","key":"1076_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4088\/JCP.08m04912gre","volume":"71","author":"RM Procyshyn","year":"2010","unstructured":"Procyshyn RM, Honer WG, Wu TK, Ko RW, McIsaac SA, Young AH, Johnson JL, Barr AM: Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. J Clin Psychiatry. 2010, 71 (5): 566-573. 10.4088\/JCP.08m04912gre.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"1076_CR16","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1185\/03007990903102966","volume":"25","author":"J Karagianis","year":"2009","unstructured":"Karagianis J, Williams R, Davis L, et al: Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia. Curr Med Res Opin. 2009, 25 (9): 2121-2132. 10.1185\/03007990903102966.","journal-title":"Curr Med Res Opin"},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2006.00756.x","volume":"430","author":"G Smith","year":"2006","unstructured":"Smith G, Malla A, Williams R, Kopala L, Love L, Balshaw R: The Canadian national outcomes measurement study in Schizophrenia: overview of the patient sample and methodology. Acta Psychiatr Scand Suppl. 2006, 430: 4-11.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"6","key":"1076_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1177\/0091270009350625","volume":"50","author":"N Ranceva","year":"2010","unstructured":"Ranceva N, Ashraf W, Odelola D: Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines. J Clin Pharmacol. 2010, 50 (6): 699-704. 10.1177\/0091270009350625.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"1076_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","volume":"67","author":"R Mojtabai","year":"2010","unstructured":"Mojtabai R, Olfson M: National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010, 67 (1): 26-36. 10.1001\/archgenpsychiatry.2009.175.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"1076_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/WNF.0b013e31815cba78","volume":"31","author":"I Lerma-Carrillo","year":"2008","unstructured":"Lerma-Carrillo I, de Pablo Bruhlmann S, del Pozo ML, Pascual-Pinazo F, Molina JD, Baca-Garcia E: Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit. Clin Neuropharmacol. 2008, 31 (6): 319-332. 10.1097\/WNF.0b013e31815cba78.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"1076_CR21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/pds.1421","volume":"16","author":"N Divac","year":"2007","unstructured":"Divac N, Jasovic-Gasic M, Samardzic R, Lackovic M, Prostran M: Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia. Pharmacoepidemiol Drug Saf. 2007, 16 (11): 1250-1251. 10.1002\/pds.1421.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1076_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a006928","volume":"28","author":"RE Clark","year":"2002","unstructured":"Clark RE, Bartels SJ, Mellman TA, Peacock WJ: Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull. 2002, 28 (1): 75-84. 10.1093\/oxfordjournals.schbul.a006928.","journal-title":"Schizophr Bull"},{"issue":"4","key":"1076_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4088\/JCP.v65n0408","volume":"65","author":"AL Miller","year":"2004","unstructured":"Miller AL, Hall CS, Buchanan RW, et al: The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry. 2004, 65 (4): 500-508. 10.4088\/JCP.v65n0408.","journal-title":"J Clin Psychiatry"},{"issue":"2 Suppl","key":"1076_CR24","first-page":"1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J: Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004, 161 (2 Suppl): 1-56.","journal-title":"Am J Psychiatry"},{"key":"1076_CR25","unstructured":"Ministerio dSyC: Gu\u00eda de pr\u00e1ctica cl\u00ednica para la atenci\u00f3n al paciente con esquizofrenia. Available at: http:\/\/www.gencat.cat\/salut\/depsan\/units\/aatrm\/pdf\/gpc_esquizofrenia-aatrm09.pdf"},{"key":"1076_CR26","unstructured":"American PA: Guideline for the treatment of patients with schizophrenia [monograf\u00eda en Internet]. Available at: http:\/\/www.pbhcare.org\/pubdocs\/upload\/documents\/APA%20Schzophrenia%20Guidelines%202004.pdf"},{"key":"1076_CR27","unstructured":"Texas MAPT: Algorithm for the Treatment of Schizophrenia."},{"issue":"2","key":"1076_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/schbul\/sbn018","volume":"35","author":"CU Correll","year":"2009","unstructured":"Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S: Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull. 2009, 35 (2): 443-457. 10.1093\/schbul\/sbn018.","journal-title":"Schizophr Bull"},{"issue":"2","key":"1076_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/schbul\/sbn030","volume":"35","author":"C Barbui","year":"2009","unstructured":"Barbui C, Signoretti A, Mule S, Boso M, Cipriani A: Does the addition of a second antipsychotic drug improve clozapine treatment?. Schizophr Bull. 2009, 35 (2): 458-468. 10.1093\/schbul\/sbn030.","journal-title":"Schizophr Bull"},{"key":"1076_CR30","doi-asserted-by":"crossref","unstructured":"Cipriani A, Boso M, Barbui C: Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev. 2009, CD006324-3","DOI":"10.1002\/14651858.CD006324.pub2"},{"issue":"10","key":"1076_CR31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1176\/ajp.151.10.1409","volume":"151","author":"JD Hegarty","year":"1994","unstructured":"Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G: One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry . 1994, 151 (10): 1409-1416.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1076_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","volume":"63","author":"PB Jones","year":"2006","unstructured":"Jones PB, Barnes TR, Davies L, et al: Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry. 2006, 63 (10): 1079-1087. 10.1001\/archpsyc.63.10.1079.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1076_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","volume":"161","author":"DG Robinson","year":"2004","unstructured":"Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004, 161 (3): 473-479. 10.1176\/appi.ajp.161.3.473.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1076_CR34","first-page":"62","volume":"24","author":"JM Kane","year":"1988","unstructured":"Kane JM, Honigfeld G, Singer J, Meltzer H: Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull. 1988, 24 (1): 62-67.","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"1076_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","volume":"163","author":"JP McEvoy","year":"2006","unstructured":"McEvoy JP, Lieberman JA, Stroup TS, et al: Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006, 163 (4): 600-610. 10.1176\/appi.ajp.163.4.600.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1076_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/schbul\/sbj067","volume":"32","author":"SW Lewis","year":"2006","unstructured":"Lewis SW, Barnes TR, Davies L, et al: Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006, 32 (4): 715-723.","journal-title":"Schizophr Bull"},{"issue":"2","key":"1076_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4088\/JCP.08m04818yel","volume":"71","author":"L Baandrup","year":"2009","unstructured":"Baandrup L, Gasse C, Jensen VD, et al: Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case\u2013control study. J Clin Psychiatry. 2009, 71 (2): 103-108.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1076_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/00002018-200831010-00002","volume":"31","author":"C Tranulis","year":"2008","unstructured":"Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E: Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf. 2008, 31 (1): 7-20. 10.2165\/00002018-200831010-00002.","journal-title":"Drug Saf"},{"issue":"1","key":"1076_CR39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18553\/jmcp.2005.11.1.17","volume":"11","author":"SJ Kogut","year":"2005","unstructured":"Kogut SJ, Yam F, Dufresne R: Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. J Manag Care Pharm. 2005, 11 (1): 17-24.","journal-title":"J Manag Care Pharm"},{"issue":"7\u20138","key":"1076_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1345\/aph.1C420","volume":"37","author":"JE Schumacher","year":"2003","unstructured":"Schumacher JE, Makela EH, Griffin HR: Multiple antipsychotic medication prescribing patterns. Ann Pharmacother. 2003, 37 (7\u20138): 951-955.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"1076_CR41","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1345\/aph.1L155","volume":"42","author":"M Yang","year":"2008","unstructured":"Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA: Antipsychotic medication utilization trends among Texas veterans: 1997\u20132002. Ann Pharmacother. 2008, 42 (9): 1229-1238. 10.1345\/aph.1L155.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"1076_CR42","doi-asserted-by":"publisher","first-page":"e3150","DOI":"10.1371\/journal.pone.0003150","volume":"3","author":"D Pickar","year":"2008","unstructured":"Pickar D, Vinik J, Bartko JJ: Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use. PLoS One. 2008, 3 (9): e3150-10.1371\/journal.pone.0003150.","journal-title":"PLoS One"},{"issue":"3","key":"1076_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","volume":"153","author":"J Usall","year":"2007","unstructured":"Usall J, Suarez D, Haro JM: Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 2007, 153 (3): 225-231. 10.1016\/j.psychres.2006.09.016.","journal-title":"Psychiatry Res"},{"issue":"6","key":"1076_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.pra.0000341890.05383.45","volume":"14","author":"AK Pandurangi","year":"2008","unstructured":"Pandurangi AK, Dalkilic A: Polypharmacy with second-generation antipsychotics: a review of evidence. J Psychiatr Pract. 2008, 14 (6): 345-367. 10.1097\/01.pra.0000341890.05383.45.","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"1076_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10488-006-0075-x","volume":"34","author":"T Uttaro","year":"2007","unstructured":"Uttaro T, Finnerty M, White T, Gaylor R, Shindelman L: Reduction of concurrent antipsychotic prescribing practices through the use of PSYCKES. Adm Policy Ment Health. 2007, 34 (1): 57-61. 10.1007\/s10488-006-0075-x.","journal-title":"Adm Policy Ment Health"},{"issue":"5","key":"1076_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1017\/S003329170700147X","volume":"38","author":"A Thompson","year":"2008","unstructured":"Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, Sipos A, Harrison G: The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. Psychol Med. 2008, 38 (5): 705-715.","journal-title":"Psychol Med"},{"issue":"1","key":"1076_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.163.1.5","volume":"163","author":"TR Insel","year":"2006","unstructured":"Insel TR: Beyond efficacy: the STAR*D trial. Am J Psychiatry. 2006, 163 (1): 5-7. 10.1176\/appi.ajp.163.1.5.","journal-title":"Am J Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T18:48:24Z","timestamp":1642272504000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-42","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]},"article-number":"42"}}